Ditchcarbon
  • Contact
  1. Organizations
  2. EMS
Public Profile
Pharmaceutical Preparation Manufacturing
BR
updated 3 months ago

EMS Sustainability Profile

Company website

EMS, officially known as EMS S/A, is a leading Brazilian pharmaceutical company headquartered in Jaguariúna, São Paulo. Founded in 1964, EMS has established itself as a key player in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic and branded medications. With a strong presence across Brazil and significant operations in Latin America, EMS has achieved notable milestones, including becoming one of the largest pharmaceutical companies in Brazil. The company is renowned for its extensive portfolio of high-quality products, which includes prescription medications, over-the-counter drugs, and a variety of therapeutic classes. EMS distinguishes itself through its commitment to innovation and quality, ensuring that its offerings meet the highest industry standards. With a robust market position, EMS continues to contribute significantly to the healthcare sector, making it a trusted name among healthcare professionals and patients alike.

DitchCarbon Score

How does EMS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

EMS's score of 32 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.

53%

Let us know if this data was useful to you

EMS's reported carbon emissions

In 2022, EMS, headquartered in Brazil, reported total carbon emissions of approximately 22,000,490 kg CO2e. This figure includes 18,242,150 kg CO2e from Scope 1 emissions, 3,668,750 kg CO2e from Scope 2 emissions, and 3,771,590 kg CO2e from Scope 3 emissions. The data reflects a comprehensive approach to emissions reporting, as all three scopes have been disclosed. Despite the significant emissions figures, EMS has not established specific reduction targets or climate pledges as of the latest data. The emissions data is cascaded from its parent company, EMS S.A., indicating a corporate family relationship that influences its climate commitments and reporting practices. As a current subsidiary, EMS is part of a broader commitment to sustainability, although specific initiatives or targets have not been detailed in the available information. The company continues to monitor its emissions and may align future strategies with industry standards and best practices in climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2022
Scope 1
18,242,150
Scope 2
3,668,750
Scope 3
3,771,590

How Carbon Intensive is EMS's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. EMS's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is EMS's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for EMS is in BR, which has a very low grid carbon intensity relative to other regions.

EMS's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

EMS has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare EMS's Emissions with Industry Peers

Eurofarma

BR
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Genentech USA, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Hypera Pharma

BR
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Aventis Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Laboratorios Bago De Bolivia S.A.

BO
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Abbott

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 5 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251107.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy